Ranking · Winter 2020 · Healthcare · Drug Discovery and Delivery

Abalone Bio

We create activating antibodies to treat diseases others can’t.

5.5%

odds of being acquired in the next two years

0.8× the average (6.8%)

#3105 of 4,339 active YC companies · top 73%

Team of 14 · San Francisco, CA, USA

Raises the odds

↑ based in United States of America

↑ based in America / Canada

↑ changed its name (pivot)

↑ tag: Machine Learning

Lowers the odds

↓ industry: Healthcare

↓ sector: Drug Discovery and Delivery

↓ “create” in its one-liner

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Abalone Bio's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

abalonebio.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub